Balchem Q1 2022: Record sales $228.9M, GAAP EPS $0.89, adjusted EPS $1.03, all segments up double-digit

BALCHEM CORP

2022-Q1 EPS reported $0.89 revenue$228,867,000

Net sales $228.9M (+23.3% YoY); GAAP net earnings $28.9M (+23.6% YoY); diluted GAAP EPS $0.89.
Adjusted EPS $1.03 (vs $0.87 YoY); adjusted EBITDA $53.6M (+17.2% YoY).
All three segments (Human Nutrition, Animal Nutrition, Specialty Products) delivered double-digit sales growth.
Cash from operations $7.0M; free cash flow $(2.8)M for the quarter.
Released 2021 Sustainability Report; targets 25% reduction in emissions and water usage by 2030.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.